As a pharmacist, I want to add some clinical context to this discussion on GLP-1 discontinuation weight regain.
Building on what josh_phd_bmore said — the evidence base here is robust. The key publications to reference are from the FLOW program[1].
Key clinical points:
- Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
- Side effect profile is predictable and usually manageable with standard protocols
- Monitoring should include baseline labs and follow-up at 3-month intervals
- Patient education significantly improves outcomes and adherence
Standard disclaimer: this is educational, not individualized medical advice.
[1] See thread title for relevant study identification.
Reading this thread on GLP-1 discontinuation hits close to home. Dad of 2 checking in — I started at 285 lbs and felt like I would tried everything.
11 months on tirz and I am a different person. Not just the 60 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about GLP-1 discontinuatio — take the leap. It was the best health decision I have ever made. ❤️
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDr.PeteFamMed — that is really helpful context on GLP-1 discontinuation. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
To answer TomTeleRx's question specifically:
From a clinical standpoint, GLP-1 discontinuation weight is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.